Skip to the content
halfrx
← Foundayo (orforglipron)

Alternatives to Foundayo

Bottom line

Nothing tracked here is the same medication as Foundayo, so every alternative is a different one. If you want cheaper, it is Qsymia at $75 a month against $299. Every price below carries its source and the date it was read, which is what separates this list from the others answering the same question.

No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price

Last updated 2026-09-22 — each alternative's published price. Read and dated by Alex Seot.

What can you take instead of Foundayo?

14 alternatives are tracked here, and none is the same medication as Foundayo in another product, so every one is a different medication, started on its own dosing schedule. On published trial figures Zepbound reports 20.9%, Wegovy reports 14.9%, Wegovy pill reports 13.6% and Mounjaro reports 11.9% against 11.1% for Foundayo. Those come from separate label trials under different protocols, so the gap is not a measured difference between them. Head to head, ACHIEVE-3 found orforglipron lowered HbA1c more than oral semaglutide 7 or 14 mg over 52 weeks, in type 2 diabetes. On price the range runs $75 to $499 a month at the maintenance dose against $299 for Foundayo, every figure with its source and the date it was read beside it.

Best alternatives to Foundayo

Ordered by published trial weight loss, then by price. Every figure carries the date it was read.

1. Zepbound (tirzepatide)

The strongest approved weight-loss drug. $449/mo once titrated — or $699 if you ever miss the 45-day refill window.

A month
$449
Trial weight loss
20.9%
What it is
branded, FDA approved
Checked
2026-08-19, past 45 days
A first year
$5,637

Tirzepatide, not orforglipron. $150 a month more expensive than Foundayo.

2. Wegovy (semaglutide)

$349/mo flat across every standard dose, with no refill deadline attached. Lilly's equivalent has one.

A month
$349
Trial weight loss
14.9%
What it is
branded, FDA approved
Checked
2026-09-22
A first year
$4,237

Semaglutide, not orforglipron. $50 a month more expensive than Foundayo.

3. Wegovy pill (semaglutide)

The first GLP-1 pill approved for weight loss. NovoCare self-pay is $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and at the 25 mg dose you stay on.

A month
$299
Trial weight loss
13.6%
What it is
branded, FDA approved
Checked
2026-09-10
A first year
$3,338

Semaglutide, not orforglipron. Same price as the drug you are comparing it against.

4. Mounjaro (tirzepatide)

Zepbound's molecule under the diabetes label. Same drug, different box, different coverage rules.

A month
$499
Trial weight loss
11.9%
What it is
branded, FDA approved
Checked
2026-09-21

Tirzepatide, not orforglipron. $200 a month more expensive than Foundayo.

5. Qsymia (phentermine, topiramate)

The strongest non-GLP-1 pill, at about 10% loss — with real pregnancy restrictions.

A month
$75
Trial weight loss
9.8%
What it is
branded, FDA approved
Checked
2026-09-22

Phentermine and topiramate, not orforglipron. $224 a month cheaper than Foundayo.

6. Saxenda (liraglutide)

The first-generation GLP-1. Daily injection, half the weight loss, largely superseded.

A month
no verified price
Trial weight loss
7.4%
What it is
branded, FDA approved
Checked
—

Liraglutide, not orforglipron.

7. Ozempic (semaglutide)

Same molecule as Wegovy, approved for type 2 diabetes. $199 for two fills, then $349 to $499 a month.

A month
$349
Trial weight loss
6.4%
What it is
branded, FDA approved
Checked
2026-09-22
A first year
$4,237

Semaglutide, not orforglipron. $50 a month more expensive than Foundayo.

8. Contrave (naltrexone, bupropion)

Non-GLP-1 oral option. Modest loss, but it is a pill and it is cheap.

A month
$99
Trial weight loss
5.4%
What it is
branded, FDA approved
Checked
2026-09-22

Naltrexone and bupropion, not orforglipron. $200 a month cheaper than Foundayo.

9. Trulicity (dulaglutide)

$389 a month on the federal TrumpRx site. Lilly publishes no cash price of its own — only a copay card for the commercially insured.

A month
$389
Trial weight loss
not published
What it is
branded, FDA approved
Checked
2026-09-22

Dulaglutide, not orforglipron. $90 a month more expensive than Foundayo.

10. Phentermine (phentermine)

The cheapest weight-loss drug there is — approved for a few weeks, sold by subscription for years.

A month
no verified price
Trial weight loss
not published
What it is
generic
Checked
—

Phentermine, not orforglipron.

11. Rybelsus (semaglutide)

Novo publishes no cash price for Rybelsus, and the federal TrumpRx tablet is the Ozempic pill — a different strength on the same label.

A month
no verified price
Trial weight loss
not published
What it is
branded, FDA approved
Checked
2026-09-07

Semaglutide, not orforglipron.

12. Compounded tirzepatide (tirzepatide)

$199–$359/mo for the strongest molecule — with Eli Lilly suing the pharmacies that sell it.

A month
$199–$359 (no maintenance price)
Trial weight loss
not published
What it is
compounded, not FDA approved
Checked
2026-09-13

Tirzepatide, not orforglipron.

13. Compounded semaglutide (semaglutide)

$129–$349/mo for the same molecule — and the reason it is cheap is the reason it is risky.

A month
$129–$349 (no maintenance price)
Trial weight loss
not published
What it is
compounded, not FDA approved
Checked
2026-09-13

Semaglutide, not orforglipron.

14. Victoza (liraglutide)

Daily liraglutide for type 2 diabetes — the same molecule as Saxenda at lower doses. No cash price published.

A month
no verified price
Trial weight loss
not published
What it is
branded, FDA approved
Checked
2026-09-10

Liraglutide, not orforglipron.

Quick comparison

DrugA monthTrial lossWhat it isChecked
Foundayo (comparing against)$29911.1%branded, FDA approved2026-09-12
Zepbound$44920.9%branded, FDA approved2026-08-19
Wegovy$34914.9%branded, FDA approved2026-09-22
Wegovy pill$29913.6%branded, FDA approved2026-09-10
Mounjaro$49911.9%branded, FDA approved2026-09-21
Qsymia$759.8%branded, FDA approved2026-09-22
Saxenda—7.4%branded, FDA approved—
Ozempic$3496.4%branded, FDA approved2026-09-22
Contrave$995.4%branded, FDA approved2026-09-22
Trulicity$389—branded, FDA approved2026-09-22
Phentermine——generic—
Rybelsus——branded, FDA approved2026-09-07
Compounded tirzepatide$199–$359 (no maintenance price)—compounded, not FDA approved2026-09-13
Compounded semaglutide$129–$349 (no maintenance price)—compounded, not FDA approved2026-09-13
Victoza——branded, FDA approved2026-09-10

Trial figures come from each drug's own trial, so the column ranks published results rather than the drugs themselves. The head-to-head trials that do exist, ACHIEVE-3, are quoted above.

Where these Foundayo figures come from

  1. [1] Foundayo (orforglipron) self-pay pricing, LillyDirectprimary
  2. [2] Orforglipron availability and cost 2026secondary
  3. [3] Eli Lilly launches oral GLP-1 across US through LillyDirectsecondary
  4. [4] Foundayo (orforglipron): what it does, what it costssecondary
  5. [5] FDA prescribing information for FOUNDAYOprimary

Everything on Foundayo

Alternatives to Foundayo, answered

What is the closest alternative to Foundayo?
Nothing tracked here is the same medication as Foundayo, so every alternative below is a different one, started on its own dosing schedule. What is comparable is the trial figure and the price, both listed with their sources.
Is there a cheaper alternative to Foundayo?
Yes. Qsymia is $75 a month against $299 for Foundayo — $224 a month less, or $2,688 across a year. Both figures are the maintenance price, each with its source and the date shown in the table.
Does anything work better than Foundayo?
On trial figures, Zepbound at 20.9%, Wegovy at 14.9%, Wegovy pill at 13.6% and Mounjaro at 11.9% against 11.1% for Foundayo. Those come from separate trials rather than a head-to-head, so the gap is not a measured difference between the two — it is two measurements taken under different protocols. A head-to-head does exist: ACHIEVE-3 randomized 1,698 adults with type 2 diabetes on metformin to orforglipron 12 or 36 mg or oral semaglutide 7 or 14 mg for 52 weeks. Those are the Rybelsus doses, not the 25 mg Wegovy pill. It measured blood sugar first, and both orforglipron doses lowered HbA1c more than both semaglutide doses. (Rosenstock et al., Lancet 2026.)

Every price here carries its source and the date it was read, and anything past 45 days without a re-check is marked stale rather than quietly aging. Information only, not medical advice — which drug suits you is a question for a clinician.

Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.